Sabino Ciavarella, MD, PhD

Here you can read some thoughts about the future of Follicular Lymphoma Therapy #lymsm #flsm doi.org/10.1111/bjh.70…

We are excited to share our new study @Cancer_Cell identifying Zeb2 as a master genetic switch controlling the tumor-associated macrophage (TAM) program. Led by @FadiSheban, @TgSanPhan, @CuriousKX & @FlorianIngelfi1. (1/20) cell.com/cancer-cell/fu…

New original article in press: Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma. @StefanoLuminari

🕯 Let’s get mediastinal gray zone lymphomas out of the gray 💡 Our latest cooperative work on haematologica.org/haematologica/… Check it out and be part of the next episode ….!! @MariellaVeglia1 @GianMaria_Zeit

Does the classification of #macrophages beyond “M1 and M2” have physiological or pathological relevance? As we go into #AACR24 check out our recent paper with @ClaudioTripodo on macrophages in lymphoma

Introduction to a review series on the influence of the tumor microenvironment on the pathogenesis of B-cell lymphomas ow.ly/452P50QZ1mK #lymphoidneoplasia

@LCerchietti @BloodJournal Top review !!

Our review article on the tumor microenvironment in B-cell lymphoma, part of a series collection, is available in Blood. Full access link
authors.elsevier.com/a/1ioEY1UYwnATg @BloodJournal

Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients dlvr.it/T46gDM

Our new paper is out! @IFOMresearch with @adj_23 @csi_singapore nature.com/articles/s4146…

Computational immunogenomic approaches to predict response to cancer immunotherapies @NatRevClinOncol nature.com/articles/s4157…

Fantastic paper by Fabio Facchetti's group: doi.org/10.1007/s00428…

Happy to share out last deep learning-based tool for prognosis in DLBCL 🧠💻 -> SurvIAE: Survival prediction with Interpretable Autoencoders from Gene Expression Data 🧬, with @N_Altini, @SabCiavarella, @MariellaVeglia1 sciencedirect.com/science/articl…

Fantastic lymphoma biology session chaired by @GreenLymphoLab and @coraline_mly — these projects bringing complex multi-omics approaches into *models* of lymphoma that can be analyzed longitudinal and perturbed are so exciting! Moving from correlations ➡️ causation!

In normal and malignant human B cells, CD20 mRNA is alternatively spliced to yield 4 5′ untranslated region isoforms, some of which are translation-deficient. loom.ly/iF8yKtY #immunobiologyandimmuotherapy #lymphoidneoplasia

Online Now: Tumor-reactive T helper cells in the context of vaccination against glioma dlvr.it/SxhFBR

I’m surprised the #lymsm community aren’t giving more airtime to this fantastic study from the Shanghai group. A randomized study based on multiple sound biological concepts, with a survival signal and plenty of intriguing translational work. cell.com/cancer-cell/fu…

Our poster presented by @N_Altini at #bits2023, Bioinformatics Italian Society, on XAI applied to DLBCL for predicting Early Progressors combining DEGs and clinical determinants. @SabCiavarella @MariellaVeglia1

We are very proud to have been awarded by the scientific board of @AIIC_IngClinici as the best work in AI application on Healthcare section. A very intensive effort shared with @SabCiavarella , @MariellaVeglia1 , @volpe_dr , @TSkrypets and all colleagues from heMATHlab and POLIBA

Molecular evolution of classic #Hodgkinlymphoma revealed through whole genome sequencing of Hodgkin and #ReedSternberg cells, by @FrancescoMaura4, @LisaRoth_MD et al. bit.ly/3LZrrIw @WeillCornell #Lymsm #CancerGenomics